Humedica Completes $30M Venture Capital Funding
Omidyar Network Commits $30M to Entrepreneurship in India and Sub-Saharan Africa
USA, Writers’ Group Film Corp. Finalizes a $10M Equity Funding Agreement
USA, iGuiders Receives Second JumpStart Investment
USA, Mzinga Closes $10M Financing
Other new investor BlueCrest Venture Finance Master Fund were joined by existing investors W Capital Partners and Shared Capital Partners.
The company will use the funds to strengthen its overall financial position and increase investments in sales and marketing as well as its social software and analytics offerings.
Commenting on the round, Barry Libert, Chairman and CEO of Mzinga, said: “This additional funding will help us take advantage of the improvements we are seeing in the general corporate markets by bringing new technologies and services to market that transform the way businesses operate—ultimately enabling them to more effectively capture intellectual capital, make better decisions, and innovate faster”.
In conjunction with the funding, Jeff Samberg of Acadia Woods Partners and Mark King of BlueCrest Capital Finance have joined the Mzinga‘s board of directors, which also includes Robert Migliorino of W Capital Partners, Howard Rubin of Shared Capital Partners, Andrew Hallowell of Arcadia Partners, and Barry Libert, CEO of Mzinga.
FinSMEs
23/09/2009
Canada, Aegera Therapeutics Closes CDN$7M Debt Financing
USA, Marketo Closes Series C Financing Round
San Mateo, CA.-based Marketo, a revenue-focused marketing automation company, closed a Series C financing round led by venture capital firm Mayfield Fund.
USA, Gamma Medica-Ideas, Inc. Closes $24M Financing
Capital Resource Partners provided $5m in mezzanine debt while Bridge Bank a $5m revolving line of credit.
Funds will be used to leverage the Northridge, Ca.-based Gamma Medica-Ideas‘ digital SPECT, PET and CT technologies into clinical imaging markets. The company’s initial product, LumaGEM, is focused on significantly improving the diagnosis of cancers in women with dense breast tissue.
Dr. Bradley E Patt, Ph.D., company’s co-founder, President and Chief Executive Officer, was reported to say: “We are ready today to demonstrate the strength of the technology platform with our product that we expect will have a huge impact in improving breast cancer diagnosis. We are now aggressively marketing our FDA cleared LumaGEM product for molecular breast imaging”.
USA, Zogenix Closes $51M in Series B Preferred Stock Financing
The Carlyle Group Acquires Minority Stake in China’s Yashili Group
USA, ReVerb Networks Raises $9M Series A Financing
France, Argos Soditic portfolio company Orsyp acquires Sysload
USA, Altius Education Raises $8M Series A Funding
FinSMEs
23/09/2009